January 20, 2011
Company news: CSL Behring and McGraw-Hill
CSL Behring awarded advocacy grants worth around $100,000 to six patient groups through its Local Empowerment for Advocacy Development program, which supports groups helping patients using plasma-derived or recombinant therapies for rare and serious diseases, including bleeding disorders, immune deficiencies and hereditary angioedema.
McGraw-Hill launched mobile versions of its AccessMedicine and AccessPharmacy sites for healthcare professionals. The publisher currently supports iPhone and iPhone 3G, Android and BlackBerry Bold.